Cogent Biosciences (COGT) Other Non-Current Liabilities (2020 - 2026)

Cogent Biosciences (COGT) has 5 years of Other Non-Current Liabilities data on file, last reported at $62000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities rose 1140.0% year-over-year to $62000.0 in Q1 2026; TTM through Mar 2026 was $62000.0, a 1140.0% increase from a year earlier, with the FY2025 full-year figure at $33000.0, changed N/A from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $62000.0, up from $33000.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for COGT reached as high as $2.4 million in Q3 2025 and fell as low as $5000.0 in Q1 2025.
• Historically, Other Non-Current Liabilities has averaged $1.1 million across 3 years, with a median of $881000.0 in 2022.
• Across the five-year window, Other Non-Current Liabilities sank 44.44% in 2022 and surged 1140.0% in 2026, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $1.7 million in 2022, then sank by 98.06% to $33000.0 in 2025, then soared by 87.88% to $62000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $62000.0 in Q1 2026, $33000.0 in Q4 2025, and $2.4 million in Q3 2025.